A REVIEW OF GEEKBARR 0 1

Specimens of all labeling which includes not been previously submitted within the PMTA, prior postmarket studies, or underneath segment 905(i) with the FD&C Act and descriptions of all labeling improvements including the date the labeling was initially disseminated and the date when dissemination was wholly terminated.FDA proposes to determine “p